Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Oluwayemisi Esan & Anthony S Wierzbicki. (2020) Volanesorsen in the Treatment of Familial Chylomicronemia Syndrome or Hypertriglyceridaemia: Design, Development and Place in Therapy. Drug Design, Development and Therapy 14, pages 2623-2636.
Read now
Read now
Laura D’Erasmo, Antonio Gallo, Alessia Di Costanzo, Eric Bruckert & Marcello Arca. (2020) Evaluation of efficacy and safety of antisense inhibition of apolipoprotein C-III with volanesorsen in patients with severe hypertriglyceridemia. Expert Opinion on Pharmacotherapy 21:14, pages 1675-1684.
Read now
Read now
Bogusław Okopień, Łukasz Bułdak & Aleksandra Bołdys. (2018) Benefits and risks of the treatment with fibrates––a comprehensive summary. Expert Review of Clinical Pharmacology 11:11, pages 1099-1112.
Read now
Read now
Articles from other publishers (30)
Alan Chait. (2023) Multifactorial chylomicronemia syndrome. Current Opinion in Endocrinology, Diabetes & Obesity.
Crossref
Crossref
Batoul Jaafar, Jessica Abou Chaaya, Shahed Ammar & Ibrahim Salti. (2023) Acute pancreatitis in pregnancy and familial chylomicronemia syndrome: case report and literature review. Metabolism and Target Organ Damage 3:4.
Crossref
Crossref
Liali Aljouda, Laura Nagy & Andreas Schulze. (2023) Long-Term Treatment of Lipoprotein Lipase Deficiency with Medium-Chain Triglyceride-Enriched Diet: A Case Series. Nutrients 15:16, pages 3535.
Crossref
Crossref
Rafael H. Isaac, Deyanira Gonzalez-Devia, Carlos O. Mendivil & Edgardo Chapman. (2023) Case report: desensitization of hypersensitivity against the antisense oligonucleotide volanesorsen. Frontiers in Allergy 4.
Crossref
Crossref
Alan Chait & Kenneth R. Feingold. (2023) Approach to patients with hypertriglyceridemia. Best Practice & Research Clinical Endocrinology & Metabolism 37:3, pages 101659.
Crossref
Crossref
Anthony S Wierzbicki, Eun Ji Kim, Oluwayemisi Esan & Radha Ramachandran. (2022) Hypertriglyceridaemia: an update. Journal of Clinical Pathology 75:12, pages 798-806.
Crossref
Crossref
Daniele Tramontano, Simone Bini, Laura D’Erasmo & Marcello Arca. (2022) Recent Apolipoprotein CIII trials. Current Opinion in Lipidology 33:6, pages 309-318.
Crossref
Crossref
Alan Chait. (2022) Hypertriglyceridemia. Endocrinology and Metabolism Clinics of North America 51:3, pages 539-555.
Crossref
Crossref
Bai-Hui Zhang, Fan Yin, Ya-Nan Qiao & Shou-Dong Guo. (2022) Triglyceride and Triglyceride-Rich Lipoproteins in Atherosclerosis. Frontiers in Molecular Biosciences 9.
Crossref
Crossref
Xi May Zhen, Kuo Luong Lee, David Sullivan & Shamasunder Acharya. (2021) New diagnosis of diabetes and severe hyperlipidemia at 3 months postpartum presenting as florid diabetic retinopathy and eruptive xanthomas. Journal of Obstetrics and Gynaecology Research 48:2, pages 483-491.
Crossref
Crossref
Yundong Xie, Jiping Liu, Yongheng Shi, Bin Wang, Xiaoping Wang, Wei Wang, Meng Sun, Xinya Xu, Lifei Cheng & Shipeng He. (2021) Structural simplification and bioisostere principle lead to Bis-benzodioxole-fibrate derivatives as potential hypolipidemic and hepatoprotective agents. Bioorganic Chemistry 117, pages 105454.
Crossref
Crossref
Chatchon Kaewkrasaesin, Waralee Chatchomchuan, Suwanna Muanpetch & Weerapan Khovidhunkit. (2021) ANGPTL3 and ANGPTL8 in Thai subjects with hyperalphalipoproteinemia and severe hypertriglyceridemia. Journal of Clinical Lipidology 15:5, pages 752-759.
Crossref
Crossref
Beatriz Candás-Estébanez, Ariadna Padró-Miquel & Virginia Esteve-Luque. (2021) Bases genéticas de las hipertrigliceridemias. Clínica e Investigación en Arteriosclerosis 33, pages 14-19.
Crossref
Crossref
Scott Leopold & Justin P. Zachariah. (2021) Pediatric Lipid Disorders. Pediatric Annals 50:3.
Crossref
Crossref
Julia Cristina Coronado Arroyo, Marcio José Concepción Zavaleta, Eilhart Jorge García Villasante, Mikaela Kcomt Lam, Luis Alberto Concepción Urteaga & Francisca Elena Zavaleta Gutiérrez. (2021) Familial Chylomicronemia Syndrome-Induced Acute Necrotizing Pancreatitis during Pregnancy. Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics 43:03, pages 220-224.
Crossref
Crossref
Rami A. Ballout & Alan T. Remaley. 2021. Biochemical and Molecular Basis of Pediatric Disease. Biochemical and Molecular Basis of Pediatric Disease
965
1022
.
Vincent A Pallazola, Aparna Sajja, Robert Derenbecker, Oluseye Ogunmoroti, Jihwan Park, Vasanth Sathiyakumar & Seth S Martin. (2020) Prevalence of familial chylomicronemia syndrome in a quaternary care center. European Journal of Preventive Cardiology 27:19, pages 2276-2278.
Crossref
Crossref
Antonio Gallo, Sophie Béliard, Laura D’Erasmo & Eric Bruckert. (2020) Familial Chylomicronemia Syndrome (FCS): Recent Data on Diagnosis and Treatment. Current Atherosclerosis Reports 22:11.
Crossref
Crossref
Carsten Krueger, Ruth McWhannell & Andreas Schulze. (2020) Vomiting in a 40-day-old Infant with Consanguineous Parents. Pediatrics in Review 41:Supplement 1, pages S91-S93.
Crossref
Crossref
Amitabh V. Nimonkar, Stephen Weldon, Kevin Godbout, Darrell Panza, Susan Hanrahan, Rose Cubbon, Fangmin Xu, John W. Trauger, Jiaping Gao & Andrei Voznesensky. (2020) A lipoprotein lipase–GPI-anchored high-density lipoprotein–binding protein 1 fusion lowers triglycerides in mice: Implications for managing familial chylomicronemia syndrome. Journal of Biological Chemistry 295:10, pages 2900-2912.
Crossref
Crossref
Ricky Lali, Edward Cui, Aida Ansarikaleibari, Marie Pigeyre & Guillaume Paré. (2019) Genetics of early-onset coronary artery disease. Current Opinion in Cardiology 34:6, pages 706-713.
Crossref
Crossref
Anthony S. Wierzbicki & Timothy M. Reynolds. (2019) Genetic risk scores in lipid disorders. Current Opinion in Cardiology 34:4, pages 406-412.
Crossref
Crossref
Alan ChaitRobert H. Eckel. (2019) The Chylomicronemia Syndrome Is Most Often Multifactorial. Annals of Internal Medicine 170:9, pages 626.
Crossref
Crossref
Mariko Harada-Shiba. (2019) How much further do we need to decrease LDL cholesterol levels in heterozygous familial hypercholesterolemia?. Atherosclerosis 284, pages 218-220.
Crossref
Crossref
Vladimir N. Titov & Alevtina P. Schekotova. (2019) Oleic, palmitic triglycerides, very low density lipoproteins. Atherosclerosis, arterial atheromatosis and ischemic heart disease pathogenesis. Perm Medical Journal 36:1, pages 102-117.
Crossref
Crossref
Emmanuel Eroume-A. Egom, Rebabonye B. Pharithi, Soressa Hesse, Neasa Starr, Richard Armstrong, Habitha Mohammed Sulaiman, Katarina Gazdikova, Ioana Mozos, Martin Caprnda, Peter Kubatka, Peter Kruzliak, Barkat Khan, Ludovit Gaspar & Vincent M. G. Maher. (2019) Latest Updates on Lipid Management. High Blood Pressure & Cardiovascular Prevention.
Crossref
Crossref
David M. Ng, John R. Burnett, Damon A. Bell, Robert A. Hegele & Amanda J. Hooper. (2019) Update on the diagnosis, treatment and management of rare genetic lipid disorders. Pathology 51:2, pages 193-201.
Crossref
Crossref
Manuel Castro Cabezas, Benjamin Burggraaf & Boudewijn Klop. (2018) Dyslipidemias in clinical practice. Clinica Chimica Acta 487, pages 117-125.
Crossref
Crossref
Xavier Pintó Sala & Virginia Esteve Luque. (2018) El concepto de hipertrigliceridemia severa y sus implicaciones para la práctica clínica. Clínica e Investigación en Arteriosclerosis 30:5, pages 193-196.
Crossref
Crossref
Xavier Pintó Sala & Virginia Esteve Luque. (2018) The concept of severe hypertriglyceridaemia and its implications for clinical practice. Clínica e Investigación en Arteriosclerosis (English Edition) 30:5, pages 193-196.
Crossref
Crossref